Pharming Group N.V. Stock Forecast
NASDAQ: PHARHealthcareBiotechnologyUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
PHAR analyst consensus
Consensus (3 analysts)
strong_buy
Avg. price target
$34.35+255.96%
- Strong buy 0
- Buy 3
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 3 Wall Street analysts covering Pharming Group N.V. (2026-10-08), 3 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $34.35, with a high estimate of $39.00 and a low estimate of $23.40. The average target implies upside of 256.0% from the current price of $9.65.
The spread between the highest and lowest targets is 66.7%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for PHAR.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 3 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $23.40 | +142.49% |
| Average target | $34.35 | +255.96% |
| High target | $39.00 | +304.15% |